Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07013396 · ClinicalTrials.gov registry record · NA
A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler
A NA study, sponsored by Virginia Commonwealth University.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07013396 is a NA study that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 100 participants.
The verdict
NCT07013396, a NA study, has not yet begun recruiting, sponsored by Virginia Commonwealth University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Endovascular therapy (EVT) has proven to be more beneficial for patients with AIS caused by large vessel occlusions (LVO) than medical management alone. A recent meta-analysis of 5 RCTs showed that EVT significantly reduced disability at 90 days compared to medical management \[1\]. Despite its obvious benefits, patients may have neurological deterioration despite successful thrombectomy due to ischemia progression, intracranial hemorrhage, re-occlusion, or vasogenic edema. The incidence of early neurological deterioration (END) following EVT for acute stroke has been reported to be ranging from 14.1-35.2% with some studies defining END up to 7 days and some restricting the definition between 6-72 hours post thrombectomy. A small proportion of these patients, approximately 5.9-10.5%, experienced sICH following EVT. Whether END occurs due to ischemic or hemorrhagic it leads to worse outcomes.
Interventions
- OTHER TCD measurement
- OTHER TCD parameters
- OTHER Baseline characteristics
- OTHER Clinical data will be collected
- OTHER All follow-up patients receive a phone call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2027-02 |
| Est. Completion | 2027-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07013396
The ClinicalTrials.gov registry entry for NCT07013396 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which TCD measurement is the first listed.
NCT07013396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07013396 about?
NCT07013396 is a clinical study titled "A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler". Endovascular therapy (EVT) has proven to be more beneficial for patients with AIS caused by large vessel occlusions (LVO) than medical management alone. A recent meta-analysis of 5 RCTs showed that EVT significantly reduced disability at 90 days compared to medical management \[1\]. Despite its obvi...
What is the current status of trial NCT07013396?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2027-02. Estimated completion is 2027-02.
What interventions are being tested in trial NCT07013396?
The interventions under investigation include: TCD measurement (OTHER), TCD parameters (OTHER), Baseline characteristics (OTHER), Clinical data will be collected (OTHER), All follow-up patients receive a phone call (OTHER).
Who is sponsoring clinical trial NCT07013396?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.